DuPont Capital Management Corporation »

Aeon Biopharma I shares owned by DuPont Capital Management Corporation

Quarter-by-quarter ownership of Aeon Biopharma I (AEON.WS) shares owned by DuPont Capital Management Corporation from 13F filings

Historical chart of DuPont Capital Management Corporation investment in Aeon Biopharma I

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma I held by DuPont Capital Management Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma I by DuPont Capital Management Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $73k 50k 1.45
2023-12-31 $4.4k 50k 0.09
2023-09-30 $7.5k 50k 0.15

More positions owned by DuPont Capital Management Corporation

Corteva Common Stock Usd.01 (CTVA)
Microsoft Corp Common Stock Usd.00000625 (MSFT)
Nvidia Corp Common Stock Usd.001 (NVDA)
Apple Common Stock Usd.00001 (AAPL)
Amazon.com Common Stock Usd.01 (AMZN)
Alphabet Inc Cl C Common Stock Usd.001 (GOOG)
Vanguard Ftse Emerging Markets Vanguard Ftse Emerging Marke (VWO)
Meta Platforms Inc Class A Common Stock Usd.000006 (META)
Mastercard Inc A Common Stock Usd.0001 (MA)
Ishares Msci Emerging Markets Ishares Msci Emerging Market (EEM)
Taiwan Semiconductor Sp Adr (TSM)
Jpmorgan Chase Common Stock Usd1.0 (JPM)
Invesco S P 500 Equal Weight E Invesco S+p 500 Equal Weight (RSP)
Eli Lilly Common Stock (LLY)
Unitedhealth Group Common Stock Usd.01 (UNH)

View all positions for DuPont Capital Management Corporation

Top funds holding Aeon Biopharma I

Cantor Fitzgerald, L. P.
Davidson Kempner Capital Management
Aristeia Capital
LMR Partners
Tenor Capital Management
D. E. Shaw & Co
Millennium Management
Hudson Bay Capital Management
Whitebox Advisors
Wolverine Asset Management
Kim
Calamos Advisors
Goldman Sachs Group
Sandia Investment Management
Walleye Trading Advisors

View all funds holding Aeon Biopharma I